Number of times application-wise in RII Category at cut-off price?
534. CLD| Link| Bookmark|
May 2, 2016 10:36:52 PM
Top Contributor (500+ Posts, 100+ Likes)
I had tried to apply for Thyrocare on 29.04 from Axis bank ASBA but failed. Although 15200 was available in the a/c yet it was showimg required funds not available. I had ensured to apply for one lot in retail category. Today again I tried for one lot of Ujjivan but failed with the same reasons. Have I made any mistake anywhere ? People who applied through Axis may comment
Two companies — Quess Corp and Advanced Enzyme Technologies — have received securities regulator SEBI’s approval to float initial public offerings.
Staffing services provider Quess Corp received clearance from the regulator on April 26, according to the latest update. According to the draft papers, the company plans to mop up Rs 400 crore through its IPO.
Advanced Enzyme Technologies, which filed its draft papers in January, obtained clearance from the regulator on April 29.
The company’s IPO comprises fresh issue of shares aggregating to Rs 60 crore and an OFS of up to 44.73 lakh shares. Advanced Enzyme is engaged in the R&D, manufacturing and marketing of proprietary enzyme products.
Ujjivan Financial Services, a microfinance company with a licence to convert to a small finance bank, saw tremendous demand for its shares in its first public share sale, which ended on Monday.
The company’s IPO was subscribed 41 times. Bengaluru-based Ujjivan wanted to raise Rs 875-882 crore from the market, with its shares being priced in the Rs 207-210 band. By 7.30 p.m. on Monday, retail investors had bid 3.99 times while institutional investors bid 34.33 times.
HNI investors showed the most enthusiasm, bidding for 136.25 times their portion. Before the bid/issue period opened, the company raised Rs 264.75 crore from anchor investors.
As on 02-May-2016 21:00:02 IST Per NSE site for all exchanges.
Still No sms or email for the successful bid :(( Hate u SBH
Total Issue Size 2,96,63,706 Total Bids Received 1,20,67,97,760 Total Bids Received at Cut-off Price 5,18,51,520 No. of times issue is subscribed 40.68
Ma''m, total no of applications? At least this time I got it right @msg 749. Surprassed expectations in retail. If issue is reasonably priced, response will be there.
505. Eagleye May 2, 2016 4:33:55 PM IST Reply UJJIVAN FINANCIAL SERVICES LIMITED (Refer Page No 237 of RHP dated 13th April 2016)
05/May/16 – Finalisation of Basis of Allotment 06/May/16 – Unblocking of Funds from ASBA 09/May/16 – Credit of Equity Shares to Demat Account 10/May/16 – Commencement of Trading on NSE/BSE
Hey I''m new in this segment will you please let me know few things i.e. what is GMP? how listing price were arrive at the time of listing? how allotment made in the case of oversubscription? will be highly obliged you put your kind reply on same.
Equites was more heavily subscribed than ujjivan keeping in consideration number of shares reserved for HNI and retail
29.73millions for HNI and 69.38 million for retail(EQUITAS) compared to 6.34million&14.79million respectively (ujjivan) EQUITAS will give better return than ujjivan as far as it''s price comparison is taken into account
516.1. Eagleye| Link| Bookmark|
May 2, 2016 6:24:26 PM
IPO Guru (6600+ Posts, 21900+ Likes)
Dear Indy,
Equitas ... QIB was 15.05X = Rs.6,542 Crs of application value NII was 57.47X = Rs.18,740 Crs of application value RII was 1.41X = Rs.1,071 Crs of application value
Compare that with Ujjivan ... QIB is 34.33X = Rs.6,060 Crs of application value NII is 136.25X = Rs.18,036 Crs of application value RII is 3.94X = Rs.1,218 Crs of application value for Ujjivan ... RII is still uploading ...
and also keep in mind that Ujjivan has had the left-over of money after Thyrocare IPO
My dear Eagle eye In response to Ur reply we as investors are more concerned about price appreciation Which means for 100rs appreciation for equitas Ujjivan will have to appreciate approximate 200rs for same return which can be more soft for Equitas Next?